PathAI, a global leader in AI-powered pathology, today announced a strategic collaboration with University Hospital Zurich ...

FLGT currently has a market capitalization of $853.49 million.

Alzheimer’s disease biomarkers measured from finger-prick dried blood samples closely match standard plasma tests and predict ...

An exam meant to determine whether a baby was born dead or alive is of “questionable value,” the National Association of ...

A groundbreaking international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using ...

A new international study has demonstrated that Alzheimer's disease biomarkers can be accurately detected using simple finger ...

Obesity may quietly fast-forward Alzheimer’s disease, with blood tests revealing the change years earlier than expected.

The new self-sampling method, which is done at home and the dry sample sent by post, could make Alzheimer's testing much more ...

Researchers at the University of Washington have developed a rapid test that quickly detects hepatitis C, but insurance ...

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

Industry leaders say demand for these higher-value tests aimed at early disease detection, personalised treatment and long-term health management has been expanding far faster than routine pathology ...